• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

MF6:GR

6.535 EUR 0.025 0.38%

As of 13:15:03 ET on 07/31/2014.

Snapshot for MagForce AG (MF6)

Open: 6.560 Day's Range: 6.410 - 6.848 Volume: 41,555
Previous Close: 6.560 52wk Range: 2.310 - 6.900 1-Yr Rtn: +139.03%

Stock Chart for MF6

No chart data available.
  • MF6:GR 6.698
  • 1D
  • 1M
  • 1Y
6.560
Interactive MF6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MF6

Current P/E Ratio (ttm) 97.5373
Estimated P/E(12/2014) -
Relative P/E vs. DAX 5.5506
Earnings Per Share (EUR) (ttm) 0.0670
Est. EPS (EUR) (12/2014) -0.2300
Est. PEG Ratio -
Market Cap (M EUR) 156.33
Shares Outstanding (M) 23.92
30 Day Average Volume 25,080
Price/Book (mrq) 10.7178
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MF6

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MF6

Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.

Benjamin J Lipps "Ben"Chairman-Mgmt Board/CEOChristian Von VolkmannCFO/Member-Mgmt Board
Hoda TawfikCOO/Member-Mgmt Board
More Company Profile & Key Executives for MF6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil